A Novel FK506 Binding Protein Can Mediate the Immunosuppressive Effects of FK506 and Is Associated with the Cardiac Ryanodine Receptor (*)

FK506, an immunosuppressant that prolongs allograft survival, is a co-drug with its intracellular receptor, FKBP12. The FKBP12•FK506 complex inhibits calcineurin, a critical signaling molecule during T-cell activation. FKBP12 was, until recently, the sole FKBP known to mediate calcineurin inhibition at clinically relevant FK506 concentrations. The best characterized cellular function of FKBP12 is the modulation of ryanodine receptor isoform-1, a component of the calcium release channel of skeletal muscle sarcoplasmic reticulum. Recently, a novel protein, FKBP12.6, was found to inhibit calcineurin at clinically relevant FK506 concentrations. We have cloned the cDNA encoding human FKBP12.6 and characterized the protein. In transfected Jurkat cells, FKBP12.6 is equivalent to FKBP12 at mediating the inhibitory effects of FK506. Upon binding rapamycin, FKBP12.6 complexes with the 288-kDa mammalian target of rapamycin. In contrast to FKBP12, FKBP12.6 is not associated with ryanodine receptor isoform-1 but with the distinct ryanodine receptor isoform-2 in cardiac muscle sarcoplasmic reticulum. Our results suggest that FKBP12.6 has both a unique physiological role in excitation-contraction coupling in cardiac muscle and the potential to contribute to the immunosuppressive and toxic effects of FK506 and rapamycin.

[1]  A. P. Timerman,et al.  Characterization of an Exchange Reaction between Soluble FKBP-12 and the FKBP·Ryanodine Receptor Complex , 1995, The Journal of Biological Chemistry.

[2]  R. Abraham,et al.  Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.

[3]  D. Maclennan,et al.  Asymmetrical blockade of the Ca2+ release channel (ryanodine receptor) by 12-kDa FK506 binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Klee,et al.  Rabbit FKBP-59/HBI does not inhibit calcineurin activity in vitro. , 1994, Biochemical and biophysical research communications.

[5]  K. Nakanishi,et al.  A putative sirolimus (rapamycin) effector protein. , 1994, Biochemical and biophysical research communications.

[6]  P. Griffin,et al.  Inhibition of calcineurin by a novel FK-506-binding protein. , 1994, The Journal of biological chemistry.

[7]  Paul Tempst,et al.  RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.

[8]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[9]  A. Marks,et al.  Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein , 1994, Cell.

[10]  Y. Nakamura,et al.  Molecular cloning and expression of a novel human gene that is highly homologous to human FK506-binding protein 12kDa (hFKBP-12) and characterization of two alternatively spliced transcripts. , 1994, Biochemical and biophysical research communications.

[11]  A. P. Timerman,et al.  The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptor. , 1994, Cell calcium.

[12]  E. A. O'neill,et al.  Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B. , 1994, The EMBO journal.

[13]  A. Marks,et al.  The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. , 1994, Biochemical and biophysical research communications.

[14]  F. Dumont,et al.  Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes. , 1994, The Journal of pharmacology and experimental therapeutics.

[15]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.

[16]  J. Springer,et al.  FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. , 1994, The Journal of biological chemistry.

[17]  A. Marks,et al.  The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. , 1993, The Journal of biological chemistry.

[18]  S. Snyder,et al.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Galat,et al.  Peptidylproline cis-trans-isomerases: immunophilins. , 1993, European journal of biochemistry.

[20]  S. Schreiber,et al.  Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location , 1993, Molecular and cellular biology.

[21]  T. Kuno,et al.  Detection of the FK506-FKBP-calcineurin complex by a simple binding assay. , 1993, Biochemical and biophysical research communications.

[22]  J J Burbaum,et al.  Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis. , 1993, The Journal of biological chemistry.

[23]  S. Schreiber,et al.  A composite FKBP12-FK506 surface that contacts calcineurin , 1993 .

[24]  S. Schreiber,et al.  Activation of an inactive immunophilin by mutagenesis , 1993 .

[25]  N. Sigal,et al.  Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex. , 1992, The Journal of biological chemistry.

[26]  F. Dumont,et al.  The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin , 1992, The Journal of experimental medicine.

[27]  R. Kincaid,et al.  Structure and expression of two isoforms of the murine calmodulin-dependent protein phosphatase regulatory subunit (calcineurin B). , 1992, Biochemical and biophysical research communications.

[28]  P. Greengard,et al.  Calcineurin mediates alpha-adrenergic stimulation of Na+,K(+)-ATPase activity in renal tubule cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Crabtree,et al.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation , 1992, Nature.

[30]  E. A. O'neill,et al.  FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin , 1992, Nature.

[31]  H. Erdjument-Bromage,et al.  FK506 binding protein associated with the calcium release channel (ryanodine receptor). , 1992, The Journal of biological chemistry.

[32]  Jun O. Liu,et al.  Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. , 1992, Biochemistry.

[33]  N. Sigal,et al.  Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction , 1992 .

[34]  S. Schreiber,et al.  The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.

[35]  M. Kozak.  Structural features in eukaryotic mRNAs that modulate the initiation of translation. , 1991, The Journal of biological chemistry.

[36]  J. H. Collins.  Sequence analysis of the ryanodine receptor: possible association with a 12K, FK506-binding immunophilin/protein kinase C inhibitor. , 1991, Biochemical and biophysical research communications.

[37]  R F Standaert,et al.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex , 1991, Science.

[38]  N. Sigal,et al.  The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. , 1990, The Journal of biological chemistry.

[39]  J. Nakai,et al.  Primary structure and functional expression from cDN A of the cardiac ryanodine receptor/calcium release channel , 1990, FEBS letters.

[40]  H. Willard,et al.  Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. , 1990, The Journal of biological chemistry.

[41]  R. Kincaid,et al.  Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. , 1990, The Journal of biological chemistry.

[42]  R. Stein,et al.  Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. , 1990, Biochemistry.

[43]  Jun O. Liu,et al.  Cloning, expression, and purification of human cyclophilin in Escherichia coli and assessment of the catalytic role of cysteines by site-directed mutagenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Nolan H. Sigal,et al.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.

[45]  S. Thiru,et al.  RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING , 1989, The Lancet.

[46]  S. Fleischer,et al.  Positive cooperativity of ryanodine binding to the calcium release channel of sarcoplasmic reticulum from heart and skeletal muscle. , 1989, Biochemistry.

[47]  S. Fleischer,et al.  Biochemistry and biophysics of excitation-contraction coupling. , 1989, Annual review of biophysics and biophysical chemistry.

[48]  P. Cohen.  The structure and regulation of protein phosphatases. , 1989, Annual review of biochemistry.

[49]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Fleischer,et al.  Identification and purification of a transverse tubule coupling protein which binds to the ryanodine receptor of terminal cisternae at the triad junction in skeletal muscle. , 1988, The Journal of biological chemistry.

[51]  Shaomeng Wang,et al.  Characterization of junctional and longitudinal sarcoplasmic reticulum from heart muscle. , 1988, The Journal of biological chemistry.

[52]  K. Arai,et al.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat , 1988, Molecular and cellular biology.

[53]  S. Fleischer,et al.  Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structures. , 1987, The Journal of biological chemistry.

[54]  D. Brahams.  Human immunodeficiency virus and the law. , 1987, Lancet.

[55]  D. Speicher,et al.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.

[56]  S. Fleischer,et al.  Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle , 1984, The Journal of cell biology.

[57]  S. Fleischer,et al.  Isolation and characterization of canine cardiac sarcoplasmic reticulum with improved Ca2+ transport properties. , 1983, The Journal of biological chemistry.

[58]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.